2009 Biopharma Deals Of The Year: Roche/Genentech, Movetis' IPO, Elan/J&J
Executive Summary
Which pharmaceutical and biotech deal-making and financing developments of the past year are the most surprising, creative or precedent-settingYou may also be interested in...
Financings Of The Fortnight: Movetis Files First European Biopharma IPO Since Early 2008
A Solution For Elan: It Strikes A Deal With J&J On Key Alzheimer's Assets
Roche Wins Genentech After Months-Long Battle
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: